Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 7, 2026
Methamphetamine-associated PAH on the Rise in the US: Geographic Trends & Disparities in Patient Demographics and Treatment Strategies
Nick H Kim, Vinicio de Jesus Perez, John Kingrey, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 28, 2019
Perfusion Imaging Distinguishes Exercise Pulmonary Arterial Hypertension at Rest
Puja Kohli, Vanessa J Kelly, Ekaterina G Kehl, et al.
Pulmonary Circulation
|
November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)
Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
JHLT Open
|
March 27, 2025
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension
Richard Channick, Sarah Medrek, Marion Delcroix, et al.
European Journal of Heart Failure
|
November 22, 2021
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
Stephan Rosenkranz, Richard Channick, Kelly M Chin, et al.
The European Respiratory Journal
|
August 19, 2017
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Sean Gaine, Kelly Chin, Gerry Coghlan, et al.
Advances in Therapy
|
November 2, 2021
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
Nazzareno Galiè, Sean Gaine, Richard Channick, et al.
Arthritis and Rheumatism
|
September 12, 2013
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension
Dinesh Khanna, Heather Gladue, Richard Channick, et al.
Journal of the American College of Cardiology
|
June 25, 2003
Beraprost therapy for pulmonary arterial hypertension
Robyn J Barst, Michael McGoon, Vallerie McLaughlin, et al.
Circulation
|
April 16, 2019
Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension
Kelly M Chin, Lewis J Rubin, Richard Channick, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 7, 2026
Methamphetamine-associated PAH on the Rise in the US: Geographic Trends & Disparities in Patient Demographics and Treatment Strategies
Nick H Kim, Vinicio de Jesus Perez, John Kingrey, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 28, 2019
Perfusion Imaging Distinguishes Exercise Pulmonary Arterial Hypertension at Rest
Puja Kohli, Vanessa J Kelly, Ekaterina G Kehl, et al.
Pulmonary Circulation
|
November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)
Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
JHLT Open
|
March 27, 2025
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension
Richard Channick, Sarah Medrek, Marion Delcroix, et al.
European Journal of Heart Failure
|
November 22, 2021
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
Stephan Rosenkranz, Richard Channick, Kelly M Chin, et al.
The European Respiratory Journal
|
August 19, 2017
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Sean Gaine, Kelly Chin, Gerry Coghlan, et al.
Advances in Therapy
|
November 2, 2021
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
Nazzareno Galiè, Sean Gaine, Richard Channick, et al.
Arthritis and Rheumatism
|
September 12, 2013
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension
Dinesh Khanna, Heather Gladue, Richard Channick, et al.
Journal of the American College of Cardiology
|
June 25, 2003
Beraprost therapy for pulmonary arterial hypertension
Robyn J Barst, Michael McGoon, Vallerie McLaughlin, et al.
Circulation
|
April 16, 2019
Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension
Kelly M Chin, Lewis J Rubin, Richard Channick, et al.
Page
of 8